Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 36

    1.

    Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases.

    Pillarisetti S, Alexander CW, Khanna I.

    Drug Discov Today. 2009 Dec;14(23-24):1098-1111. Epub 2009 Aug 27.PMID: 19716430 [PubMed - as supplied by publisher]Related articles

    2.

    Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance.

    Padmalayam I, Hasham S, Saxena U, Pillarisetti S.

    Diabetes. 2009 Mar;58(3):600-8. Epub 2008 Dec 15.PMID: 19074983 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases.

    Pillarisetti S.

    Recent Pat Cardiovasc Drug Discov. 2008 Nov;3(3):156-64. Review.PMID: 18991791 [PubMed - indexed for MEDLINE]Related articles

    4.

    iSTART 2: improvements for efficiency and effectiveness.

    Levinstein IB, Boonthum C, Pillarisetti SP, Bell C, McNamara DS.

    Behav Res Methods. 2007 May;39(2):224-32.PMID: 17695348 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    HDL elevators and mimetics--emerging therapies for atherosclerosis.

    Pal M, Pillarisetti S.

    Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):55-66. Review.PMID: 17266548 [PubMed - indexed for MEDLINE]Related articles

    6.

    Selected players in the inflammation cascade and drugs that target these inflammation genes against metastasis.

    Alikunju S, Pillarisetti S.

    Anticancer Agents Med Chem. 2006 Sep;6(5):461-8. Review.PMID: 17017855 [PubMed - indexed for MEDLINE]Related articles

    7.

    Emerging peptide therapeutics for inflammatory diseases.

    Vally M, Seenu S, Pillarisetti S.

    Curr Pharm Biotechnol. 2006 Aug;7(4):241-6. Review.PMID: 16918401 [PubMed - indexed for MEDLINE]Related articles

    8.

    Are peptides the future? Small molecule versus peptides.

    Pillarisetti S.

    Curr Pharm Biotechnol. 2006 Aug;7(4):225-7. No abstract available. PMID: 16918398 [PubMed - indexed for MEDLINE]Related articles

    9.

    Vascular lipases, inflammation and atherosclerosis.

    Hasham SN, Pillarisetti S.

    Clin Chim Acta. 2006 Oct;372(1-2):179-83. Review.PMID: 16765928 [PubMed - indexed for MEDLINE]Related articles

    10.

    Novel anti-inflammatory role for glycogen synthase kinase-3beta in the inhibition of tumor necrosis factor-alpha- and interleukin-1beta-induced inflammatory gene expression.

    Vines A, Cahoon S, Goldberg I, Saxena U, Pillarisetti S.

    J Biol Chem. 2006 Jun 23;281(25):16985-90. Epub 2006 Apr 6.PMID: 16601113 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Role of oxidative stress and inflammation in the origin of Type 2 diabetes--a paradigm shift.

    Pillarisetti S, Saxena U.

    Expert Opin Ther Targets. 2004 Oct;8(5):401-8. Review.PMID: 15469391 [PubMed - indexed for MEDLINE]Related articles

    13.

    Atherosclerosis -- new targets and therapeutics.

    Pillarisetti S, Alexander CW, Saxena U.

    Curr Med Chem Cardiovasc Hematol Agents. 2004 Oct;2(4):327-34. Review.PMID: 15320783 [PubMed - indexed for MEDLINE]Related articles

    14.

    Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression.

    Chen G, Wang D, Vikramadithyan R, Yagyu H, Saxena U, Pillarisetti S, Goldberg IJ.

    Biochemistry. 2004 May 4;43(17):4971-7.PMID: 15109255 [PubMed - indexed for MEDLINE]Related articles

    15.

    Involvement of matrix metalloproteinases and tenascin-C in elastin calcification.

    Bailey M, Pillarisetti S, Jones P, Xiao H, Simionescu D, Vyavahare N.

    Cardiovasc Pathol. 2004 May-Jun;13(3):146-55.PMID: 15081471 [PubMed - indexed for MEDLINE]Related articles

    16.

    Role of elastin in pathologic calcification of xenograft heart valves.

    Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR.

    J Biomed Mater Res A. 2003 Jul 1;66(1):93-102.PMID: 12833435 [PubMed - indexed for MEDLINE]Related articles

    17.

    New approaches for treatment of diabetic nephropathy: the endothelium as a target for drug discovery.

    Saxena U, Timmer RT, Pillarisetti S.

    Expert Opin Ther Targets. 2001 Oct;5(5):539-545.PMID: 12540281 [PubMed - as supplied by publisher]Related articles

    18.

    Lipoprotein lipase as a therapeutic target for dyslipidemia.

    Pillarisetti S, Saxena U.

    Front Biosci. 2003 Jan 1;8:d238-41. Review.PMID: 12456348 [PubMed - indexed for MEDLINE]Related articles

    19.

    A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion.

    Chen G, Paka L, Kako Y, Singhal P, Duan W, Pillarisetti S.

    J Biol Chem. 2001 Dec 28;276(52):49142-7. Epub 2001 Sep 28.PMID: 11579084 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.

    Pillarisetti S.

    Trends Cardiovasc Med. 2000 Feb;10(2):60-5. Review.PMID: 11150731 [PubMed - indexed for MEDLINE]Related articles

    21.

    Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor.

    Obunike JC, Lutz EP, Li Z, Paka L, Katopodis T, Strickland DK, Kozarsky KF, Pillarisetti S, Goldberg IJ.

    J Biol Chem. 2001 Mar 23;276(12):8934-41. Epub 2000 Dec 19.PMID: 11121409 [PubMed - indexed for MEDLINE]Related articles

    22.

    The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production.

    Obunike JC, Pillarisetti S, Paka L, Kako Y, Butteri MJ, Ho YY, Wagner WD, Yamada N, Mazzone T, Deckelbaum RJ, Goldberg IJ.

    Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):111-8.PMID: 10634807 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth?

    Paka L, Goldberg IJ, Obunike JC, Choi SY, Saxena U, Goldberg ID, Pillarisetti S.

    J Biol Chem. 1999 Dec 17;274(51):36403-8.PMID: 10593935 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Lipolysis-induced iron release from diferric transferrin: Possible role of lipoprotein lipase in LDL oxidation.

    Balagopalakrishna C, Paka L, Pillarisetti S, Goldberg IJ.

    J Lipid Res. 1999 Jul;40(7):1347-56.PMID: 10393220 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Detecting ligands interacting with lipoprotein lipase.

    Pillarisetti S.

    Methods Mol Biol. 1999;109:267-78. Review. No abstract available. PMID: 9918029 [PubMed - indexed for MEDLINE]Related articles

    27.

    The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.

    Goldberg IJ, Wagner WD, Pang L, Paka L, Curtiss LK, DeLozier JA, Shelness GS, Young CS, Pillarisetti S.

    J Biol Chem. 1998 Dec 25;273(52):35355-61.PMID: 9857078 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.

    Pillarisetti S, Paka L, Obunike JC, Berglund L, Goldberg IJ.

    J Clin Invest. 1997 Aug 15;100(4):867-74.PMID: 9259586 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Lipoprotein lipase can function as a monocyte adhesion protein.

    Obunike JC, Paka S, Pillarisetti S, Goldberg IJ.

    Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1414-20.PMID: 9261275 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Endothelial cell heparanase modulation of lipoprotein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone.

    Pillarisetti S, Paka L, Sasaki A, Vanni-Reyes T, Yin B, Parthasarathy N, Wagner WD, Goldberg IJ.

    J Biol Chem. 1997 Jun 20;272(25):15753-9.PMID: 9188470 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Surgical pathology report in the era of desktop publishing.

    Pillarisetti SG.

    Arch Pathol Lab Med. 1993 Jan;117(1):40-2.PMID: 8418760 [PubMed - indexed for MEDLINE]Related articles

    32.

    Protection for software authors.

    Pillarisetti SG.

    Am J Clin Pathol. 1989 Aug;92(2):252. No abstract available. PMID: 2756942 [PubMed - indexed for MEDLINE]Related articles

    33.

    Purification and properties of synephrinase from Arthrobacter synephrinum.

    Manne V, Kutty KR, Pillarisetti SR.

    Arch Biochem Biophys. 1986 Jul;248(1):324-34.PMID: 3729420 [PubMed - indexed for MEDLINE]Related articles

    34.

    Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.

    Espinoza CG, Pillarisetti SG, Azar HA.

    Ann Clin Lab Sci. 1984 Nov-Dec;14(6):467-73.PMID: 6210034 [PubMed - indexed for MEDLINE]Related articles

    35.

    Selected applications of immunoperoxidase techniques in surgical pathology.

    Espinoza CG, Pillarisetti SG, Azar HA.

    Ann Clin Lab Sci. 1983 May-Jun;13(3):240-8.PMID: 6307109 [PubMed - indexed for MEDLINE]Related articles

    36.

    Immunologic studies of experimental beryllium lung disease in the guinea pig.

    Barna BP, Chiang T, Pillarisetti SG, Deodhar SD.

    Clin Immunol Immunopathol. 1981 Sep;20(3):402-11. No abstract available. PMID: 7341034 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...